Furthermore, high-dose PMN treatment can stop the cell cycle by inhibition of the Akt/GSk3β signaling pathway and blocks autophagic flux by arresting AMPK-ULK1 axis to prevent the growth of GBM in cell and mouse models [48]. This evidence concerns the gene AKT1 and glioblastoma.